The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy
Abstract
To cite this article: Shamji MH, Ljørring C, Francis JN, Calderon MA, Larché M, Kimber I, Frew AJ, Ipsen H, Lund K, Würtzen PA, Durham SR. Functional rather than immunoreactive levels of IgG 4 correlate closely with clinical response to grass pollen immunotherapy. Allergy 2012; 67: 217–226. Background: Induction of allergen‐specific IgG 4 antibodies is the most consistent immunological finding in immunotherapy trials. However, quantitative assessments of IgG 4 antibodies have not proven beneficial in evaluating clinical changes during or after immunotherapy. In the current study, we investigated the relationship between clinical outcome and allergen‐specific IgG 4 titres or functional antibody responses following immunotherapy. We hypothesized that functional assays of serum IgG–associated inhibitory activity such as inhibition of IgE–allergen interactions (IgE‐blocking factor) and inhibition of CD23‐dependent IgE‐facilitated allergen binding (IgE‐FAB) correlate more closely with clinical outcome and may be biomarkers of clinical response. Methods: In an 8‐month dose–response randomized double‐blind placebo‐controlled study, 221 polysensitized subjects with severe seasonal rhinitis received Alutard SQ, Phleum pratense 100 000 SQ‐U, 10 000 SQ‐U or placebo injections. Serum specimens were collected before treatment, after up‐dosing, during the peak season and at the end of the study. Allergen‐specific IgG 4 titres and IgG‐associated inhibitory activity were evaluated. Results: A time‐ and dose‐dependent increase in serum inhibitory activity for both the IgE‐blocking factor and IgE‐FAB was observed, which paralleled increases in grass pollen–specific IgG 4 antibodies. A modest but significant inverse relationship was demonstrated between postimmunotherapy serum inhibitory activity and combined symptom–rescue medication scores (IgE‐FAB: r = −0.25, P = 0.0002; IgE‐blocking factor: r = −0.28, P < 0.0001), whereas this was not observed for immunoreactive IgG 4 levels (r = −0.11, P = 0.12). Conclusions: Functional assays of inhibitory IgG 4 and IgE‐blocking factor may be more useful surrogates of clinical response than IgG 4. Whether these antibody effects may serve as predictive biomarkers of clinical efficacy in individual patients requires further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E.-M., Jacobson, M. R., O'Brien, F., Noble, W., Till, S. J., Hamid, Q. A., & Nouri-Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,373
Self-citationAnti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange
van der Neut Kolfschoten, M., Schuurman, J., Losen, M., Bleeker, W. K., Martínez-Martínez, P., Vermeulen, E., den Bleker, T. H., Wiegman, L., Vink, T., Aarden, L. A., et al. (2007) · Science · doi:10.1126/science.1144603 · Cited by 975
Immunoglobulin G4: an odd antibody
Aalberse, R. C., Stapel, S. O., Schuurman, J., & Rispens, T. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03207.x · Cited by 818
Aalberse, R. C., van der Gaag, R., & van Leeuwen, J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.2.722 · Cited by 736
Statistical validation of intermediate endpoints for chronic diseases
Freedman, L. S., Graubard, B. I., & Schatzkin, A. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110204 · Cited by 651
Aalberse, R. C., & Schuurman, J. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01341.x · Cited by 449
van Neerven, R. J. J., Wikborg, T., Lund, G., Jacobsen, B., Brinch-Nielsen, A., Arnved, J., & Ipsen, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2944 · Cited by 384
Self-citationFrew, A. J., Powell, R. J., Corrigan, C. J., & Durham, S. R. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.11.014 · Cited by 374
Self-citationJames, L. K., Shamji, M. H., Walker, S. M., Wilson, D. R., Wachholz, P. A., Francis, J. N., Jacobson, M. R., Kimber, I., Till, S. J., & Durham, S. R. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1080 · Cited by 342
Self-citationNiggemann, B., Jacobsen, L., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Koivikko, A., Koller, D., Norberg, L. A., Urbanek, R., et al. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01068.x · Cited by 332
Francis, J. N., James, L. K., Paraskevopoulos, G., Wong, C., Calderon, M. A., Durham, S. R., & Till, S. J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.01.072 · Cited by 329
Self-citationRobinson, D. S., Larché, M., & Durham, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423595 · Cited by 313
Self-citationInhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy
Wachholz, P. A., Kristensen Soni, N., Till, S. J., & Durham, S. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)02022-0 · Cited by 299
Self-citationChristensen, L. H., Holm, J., Lund, G., Riise, E., & Lund, K. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.05.026 · Cited by 272
Self-citationMothes, N., Heinzkill, M., Drachenberg, K. J., Sperr, W. R., Krauth, M. T., Majlesi, Y., Semper, H., Valent, P., Niederberger, V., Kraft, D., et al. (2003) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2003.01699.x · Cited by 269
Scadding, G. W., Shamji, M. H., Jacobson, M. R., Lee, D. I., Wilson, D., Lima, M. T., Pitkin, L., Pilette, C., Nouri‐Aria, K., & Durham, S. R. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03462.x · Cited by 258
Self-citationSerum-IgE-facilitated allergen presentation in atopic disease
van der Heijden, F. L., Joost van Neerven, R. J., van Katwijk, M., Bos, J. D., & Kapsenberg, M. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.8.3643 · Cited by 224
GEHLHAR, SCHLAAK, BECKER, & BUFE (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00525.x · Cited by 167
Renaissance of the Blocking Antibody Concept in Type I Allergy
Flicker, S., & Valenta, R. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000073260 · Cited by 163
Performance evaluation of a specific IgE assay developed for the ADVIA centaur® immunoassay system
Petersen, A. B., Gudmann, P., Grønager, P. M., Mørkeberg, R., Bøgestrand, S., Linneberg, A. R., & Johansen, N. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.06.010 · Cited by 149
Shamji, M. H., Wilcock, L. K., Wachholz, P. A., Dearman, R. J., Kimber, I., Würtzen, P. A., Larché, M., Durham, S. R., & Francis, J. N. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.09.004 · Cited by 149
Self-citationNegative regulation of FcϵRI signaling by FcγRII costimulation in human blood basophils
Kepley, C. L., Cambier, J. C., Morel, P. A., Lujan, D., Ortega, E., Wilson, B. S., & Oliver, J. M. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107931 · Cited by 148
van Neerven, R. J. J., Knol, E. F., Ejrnaes, A. M., & Würtzen, P. A. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000094714 · Cited by 138
Self-citationAalberse, R. C., Dieges, P. H., Knul-Bretlova, V., Vooren, P. H., Aalbers, M., & van Leeuwen, J. (1983) · Clinical Reviews in Allergy · doi:10.1007/bf02991163 · Cited by 122
Würtzen, P. A., Lund, G., Lund, K., Arvidsson, M., Rak, S., & Ipsen, H. H. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03020.x · Cited by 105
Self-citationEwan, P. W., Deighton, J., Wilson, A. B., & Lachmann, P. J. (1993) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1993.tb01791.x · Cited by 92
van Neerven, R. J. J., Arvidsson, M., Ipsen, H., Sparholt, S. H., Rak, S., & Würtzen, P. A. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.01899.x · Cited by 82
Self-citationHolm, J., Willumsen, N., Würtzen, P. A., Christensen, L. H., & Lund, K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.062 · Cited by 64
Self-citationDenépoux, S., Eibensteiner, P., Steinberger, P., Vrtala, S., Visco, V., Weyer, A., Kraft, D., Banchereau, J., Valenta, R., & Lebecque, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01703-2 · Cited by 62
The role of IgG antibodies in allergy and immunotherapy
Aalberse, R. C. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02628.x · Cited by 59
IgG4 blocking effect on the release of antigen-specific histamine.
García, B. E., Ml, S., Gato, J. J., Fernández, J., & Oehling, A. K. (1993) · PubMed · Cited by 49
Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations
Movérare, R., Vesterinen, E., Metso, T., Sorva, R., Elfman, L., & Haahtela, T. (2001) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63310-8 · Cited by 25
Cited by
Sublingual immunotherapy: World Allergy Organization position paper 2013 update
Canonica, G. W., Cox, L., Pawankar, R., Baena-Cagnani, C. E., Blaiss, M., Bonini, S., Bousquet, J., Calderón, M., Compalati, E., Durham, S. R., et al. (2014) · World Allergy Organization Journal · doi:10.1186/1939-4551-7-6 · Cited by 591
Self-citationMechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers
Shamji, M. H., & Durham, S. R. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.010 · Cited by 446
Self-citationAllergen immunotherapy: past, present and future
Durham, S. R., & Shamji, M. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00786-1 · Cited by 413
Self-citationEifan, A. O., & Durham, S. R. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12780 · Cited by 379
Self-citationShamji, M. H., Kappen, J. H., Akdis, M., Jensen‐Jarolim, E., Knol, E. F., Kleine‐Tebbe, J., Bohle, B., Chaker, A. M., Till, S. J., Valenta, R., et al. (2017) · Allergy · doi:10.1111/all.13138 · Cited by 382
Self-citation
Metadata
- Authors
- Shamji, M. H., Ljørring, C., Francis, J. N., A Calderon, M., Larché, M., Kimber, I., Frew, A. J., Ipsen, H., Lund, K., Würtzen, P. A., & Durham, S. R.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2011-11-14
- Volume
- 67
- Issue
- 2
- Pages
- 217-226
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1577022278
- Cited by
- 297
- References
- 32
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.